BHONSLE SUNIL 4
4 · TITAN PHARMACEUTICALS INC · Filed Mar 9, 2018
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2018-03-07+170,000→ 170,000 totalExercise: $0.97Exp: 2028-03-07→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]The options vest as to 25% on the grant date and 25% on each of the three month, six month and nine month anniversaries of the grant date.